GSTM1 negatives tended to be associated with a better prognosis, whereas the NAT2 risk alleles rs710521(A) and rs9642880(T), detected in the first GWAS on bladder cancer (Kiemeney et al., 2008[19]) tended to be associated with a poor prognosis. Here, NAT2 is linked to urinary bladder cancer.